Sign up
Login
Friday 4th April 2014
14:00 Welcome (R. Stahel, Zürich)
I The Bases for cancer immune therapy
14:15 Basic immunology (N. Rufer, Lausanne)
14:35 Vaccines (N. Rufer, Lausanne)
14:55 Check Point Inhibitors (U. Petrausch, Zürich)
15:15 T cell engineering (L. Kandalaft, Lausanne)
15:35 Coffee break
II Immunotherapy as a transversal innovative anti cancer strategy
Melanoma
16:00 Check points inhibitors (O. Michielin, Lausanne)
16:25 Adoptive transfer (O. Michielin, Lausanne)
16:50 Perspectives/ongoing research strategy in the local network (O. Michielin, Lausanne)
Ovarian Cancer
17:00 Immunotherapy for ovarian cancer (L. Kandalaft, Lausanne)
17:30 Perspectives/ongoing research strategy in the local network (L. Kandalaft, Lausanne)
GU Cancer
17:40 Immunotherapy for prostate cancer (C. Sessa, Bellinzona)
18:10 Perspectives/ongoing research strategy in the local network (C. Sessa, Bellinzona)
18:20 Adjourn
Saturday 5th April 2014
Lung Cancer
08:00 Check points inhibitors (L. Paz-Ares, Sevilla)
08:30 Vaccines in lung cancer (J. Vansteenkiste, Leuven)
09:00 Perspectives/ongoing research strategy in the local network (S. Peters, Lausanne)
Breast Cancer
09:10 Immunotherapy for breast cancer (G. Curigliano, Milano)
09:50 Coffee break
Haematological malignancies
10:20 Immunotherapy for lymphoma and leukemia (A. Stathis, Bellinzona)
10:50 Perspectives/ongoing research strategy in the local network (A. Stathis, Bellinzona)
Brain tumors
11:00 Immunotherapy for CNS malignancies (P.-Y. Dietrich, Genève)
11:30 Perspectives/ongoing research strategy in the local network (P.-Y. Dietrich, Genève)
11:40 Wrap-up and conclusions (R. Stahel, Zürich)
12:00 End